Dr. Lorriana E. Leard, MD

Dr. Leard practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Leard's NPI, 1366459422, was assigned on August 2, 2006. Dr. Leard graduated from UC San Diego School of Medicine in 1998. Dr. Leard holds California license A79692.

Dr. Leard's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Leard's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Leard to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Leard practices. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Leard's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Leard is board certified in pulmonary disease by the American Board of Internal Medicine. Dmand AI has Dr. Leard's licenses on file in 2 states: California and Texas.

Dmand AI lists chronic obstructive pulmonary disease (COPD), pulmonary fibrosis and pulmonary heart disease among the conditions Dr. Leard treats.

CMS data shows 346 Medicare services from Dr. Leard across 7 procedure codes in 2024, for 130 Medicare patients. Medicare paid $28,105 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 130 Medicare patients who saw Dr. Leard in 2024. The largest group is 65 to 74, with 70 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 41% are also on Medicaid. Their average risk score is 3.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Leard's median patient age at 66, with 49% women.

In 2024, Dr. Leard wrote 1,209 Medicare Part D claims for 207 patients. 86% of them were for generic drugs. CMS names the drug for 987 of them, across 26 drugs with 11 or more claims each, at $240,642 in total drug cost. In 2023, CMS named 661 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Leard for performance year 2024, reported as part of a group. Dr. Leard accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Leard as offering telehealth.

Dmand AI links 59 papers to Dr. Leard, published from 2007 to 2025. 2020 was the busiest year, with 5. The most frequent topics are Lung Transplantation, Lung and Graft Rejection. Dr. Leard has published most often in J Heart Lung Transplant. Dr. Leard's most frequent co-authors are Steven R. Hays, MD, Jonathan Paul Singer, MD and Jeffrey A. Golden, MD.

CMS Open Payments shows 3 general payments to Dr. Leard from 2 drug and device companies from 2019 to 2020. Food and beverage make up the largest share, 100% of the total. United Therapeutics Corporation paid the most, $159.

Dmand AI lists 1 award for Dr. Leard, most recently CMS Stage 1 EHR in 2013.

Dr. Leard graduated from UC San Diego School of Medicine in 1998. Dr. Leard is a member of ACCP, ATS and International Society of Heart and Lung Transplantation.

Dr. Leard is in network with 9 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.